Total Funding
39
41
Total FundingSeries A raised
Growth Score 39 in past quarter
-11 pts
Heat Score 41 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
125674
DoseMe is reshaping the way that medicine is dosed with the world's first real-time precision dosing software designed for clinical care.
Acquired by 

Tabula Rasa Healthcare (formerly CareKinesis)
Charles Cornish: CEO
Robert McLeay: Founder and Chief Technology Officer
About the Company
DoseMe is unique decision support software that leverages clinically validated pharmacokinetic drug models, patient characteristics, drug concentrations and genotype to guide dose optimisation. It’s the world’s first precision dosing tool designed for clinical practice that uses Bayesian dosing methods. Its simplicity and portability means Bayesian
dosing benefits can be brought to every bedside.

